These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 12210820

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
    Franchini M, Capra F, Capelli C, de Maria E, Lippi G, Gandini G.
    Haematologica; 2001 Apr; 86(4):E12. PubMed ID: 11325664
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
    Hertzberg MS, Favaloro E, Koutts J.
    Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
    [No Abstract] [Full Text] [Related]

  • 6. Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII.
    Koyama T, Nagao T, Tsunozaki H, Arai M, Miura O.
    Pathophysiol Haemost Thromb; 2006 Aug; 35(5):405-7. PubMed ID: 17230044
    [No Abstract] [Full Text] [Related]

  • 7. On the treatment of hemorrhage in patients with hemophilia and associated inhibitors.
    Tarantino M, Aledort L.
    Transfusion; 2001 Dec; 41(12):1628-9. PubMed ID: 11778084
    [No Abstract] [Full Text] [Related]

  • 8. The treatment of bleeding in hemophilic patients with inhibitors with recombinant factor VIIa.
    Negrier C, Hay CR.
    Semin Thromb Hemost; 2000 Dec; 26(4):407-12. PubMed ID: 11092216
    [Abstract] [Full Text] [Related]

  • 9. [Bullous pemphigoid and acquired haemophilia].
    Kluger N, Navarro R, Pallure V, Guillot B.
    Ann Dermatol Venereol; 2011 May; 138(5):422-3. PubMed ID: 21570569
    [No Abstract] [Full Text] [Related]

  • 10. Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII.
    Liebman HA, Chediak J, Fink KI, Galvez AG, Shah PC, Sham RL.
    Am J Hematol; 2000 Mar; 63(3):109-13. PubMed ID: 10679799
    [Abstract] [Full Text] [Related]

  • 11. Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy.
    Conesa V, Mompel A, Lopez F, Marín F, Ruiz J, Navarro F, Gomez A.
    Am J Hematol; 2002 Aug; 70(4):329-30. PubMed ID: 12210816
    [No Abstract] [Full Text] [Related]

  • 12. [Pemphigoid and acquired hemophilia].
    Lightburn E, Morand JJ, Graffin B, Molinier S, Raphenon G, Poullin P, Harlé JR, Chouc C.
    Ann Dermatol Venereol; 2001 Nov; 128(11):1229-31. PubMed ID: 11908168
    [Abstract] [Full Text] [Related]

  • 13. Effective and safe use of recombinant factor VIIa (NovoSeven) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII.
    Leebeek FW, Kappers-Klunne MC, Jie KS.
    Haemophilia; 2004 May; 10(3):250-3. PubMed ID: 15086322
    [Abstract] [Full Text] [Related]

  • 14. The concept of recombinant factor VIIa megadose for treating bleeding episodes in high-titer inhibitor patients with hemophilia: toward an expanding indication?
    Negrier C.
    J Thromb Haemost; 2003 Mar; 1(3):423-4. PubMed ID: 12871444
    [No Abstract] [Full Text] [Related]

  • 15. Pseudoprolongation of the prothrombin time during treatment with recombinant factor VIIa for bleeding in a patient with a spontaneous factor VIII inhibitor.
    Carr ME, Kuhn JG, Martin EJ, Tidwell AR, Hagan MK.
    Int J Hematol; 2003 Apr; 77(3):308-9. PubMed ID: 12731678
    [No Abstract] [Full Text] [Related]

  • 16. Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
    Economou M, Teli A, Tzantzaroudi A, Tsatra I, Zavitsanakis A, Athanassiou-Metaxa M.
    Haemophilia; 2008 Mar; 14(2):390-1. PubMed ID: 18194305
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant factor VIIa: a review on its clinical use.
    Franchini M.
    Int J Hematol; 2006 Feb; 83(2):126-38. PubMed ID: 16513530
    [Abstract] [Full Text] [Related]

  • 18. A single high dose of recombinant factor VIIa combining adjuvant therapy for controlling bleeding episodes in haemophiliacs with inhibitors.
    Chuansumrit A, Sri-Udomporn N, Srimuninnimit V, Juntarukha R.
    Haemophilia; 2001 Sep; 7(5):532-4. PubMed ID: 11554948
    [No Abstract] [Full Text] [Related]

  • 19. Acquired hemophilia A: clinical features, surgery and treatment of 34 cases, and experience of using recombinant factor VIIa.
    Lak M, Sharifian RA, Karimi K, Mansouritorghabeh H.
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):294-300. PubMed ID: 19211581
    [Abstract] [Full Text] [Related]

  • 20. Successful use of mycophenolate mofetil and prednisone in a 14-year-old girl with acquired hemophilia A.
    Eisert S, Mosler K, Laws HJ, Göbel U.
    Thromb Haemost; 2005 Apr; 93(4):792-3. PubMed ID: 15841330
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.